[{"AccountsPayableCurrent_0_Q1_USD":8709000.0,"InvestmentIncomeNonoperating_1_Q1_USD":1491000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-175000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-2373000.0,"IncomeLossAttributableToParent_1_Q1_USD":-61833000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_1_Q1_USD":487000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":46722000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":10079000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":115489000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":511300000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":509633000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":509109000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":524000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":1505000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":513000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":229500000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":31000000.0,"AmortizationOfFinancingCosts_1_Q1_USD":44000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":643000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":6544000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":942000.0,"ShortTermInvestments_0_Q1_USD":224621000.0,"SeniorLongTermNotes_0_Q1_USD":171305000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":287379000.0,"LeaseCost_1_Q1_USD":1502000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":40979000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":12226000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":5733000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":730000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":11184000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":54500000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":159412000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1401000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":337000.0,"PaymentsForDerivativeInstrumentFinancingActivities_1_Q1_USD":28865000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":-371000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.12,"OperatingLeaseRightOfUseAsset_0_Q1_USD":25961000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":521000.0,"OperatingLeasePayments_1_Q1_USD":1677000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3627000.0,"OperatingLeaseLiability_0_Q1_USD":28517000.0,"OperatingLeaseCost_1_Q1_USD":1425000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_1_Q1_USD":247000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_1_Q1_USD":43400000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":12462000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":5057000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":6942000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5464000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":5557000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":24890000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":572000.0,"InterestExpenseDebt_1_Q1_USD":2148000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-906137000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":13967000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7171000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":539000.0,"NetIncomeLoss_1_Q1_USD":-61933000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-43289000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-105569000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":264347000.0,"LiabilitiesCurrent_0_Q1_USD":41635000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":592927000.0,"Liabilities_0_Q1_USD":284552000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":467000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":0.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":789000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":100000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.15,"CommonStockValue_0_Q1_USD":57000.0,"CommonStockSharesOutstanding_0_Q1_shares":57026154.0,"CommonStockSharesIssued_0_Q1_shares":57026154.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":286649000.0,"AssetsCurrent_0_Q1_USD":518441000.0,"Assets_0_Q1_USD":592927000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":524000.0,"Revenues_1_Q1_USD":58000.0,"StockholdersEquity_0_Q1_USD":308375000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":53868036.0,"AccruedLiabilitiesCurrent_0_Q1_USD":16178000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-61412000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":118000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1213931000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":8703000.0,"OtherAssetsNoncurrent_0_Q1_USD":1494000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-126000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":1461000.0,"OtherIntangibleAssetsNet_0_Q1_USD":32334000.0,"ShareBasedCompensation_1_Q1_USD":6544000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":21224000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39794000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":739000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":287500000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-60960000.0,"OperatingExpenses_1_Q1_USD":61018000.0,"InterestExpense_1_Q1_USD":2148000.0,"DerivativeLiabilitiesCurrent_0_Q1_USD":3042000.0,"CommonStockSharesAuthorized_0_Q1_shares":95000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockValue_0_Q1_USD":0.0,"VariableLeaseCost_1_Q1_USD":77000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]